Pharma and Lifesciences
About
It involves specialized printing techniques and technologies used to produce labels, packaging, and documentation for pharmaceutical products and life sciences applications. This sector demands high precision, compliance with stringent regulatory standards, and the ability to handle complex information accurately and consistently.
Did you Know?
It is heavily driven by regulatory compliance, with the global market for pharmaceutical packaging expected to reach approximately $149 billion by 2027. This growth is fueled by stringent labeling requirements, the rise of biologics, and increasing demand for anti-counterfeiting measures to ensure patient safety and product integrity. The global 3D bioprinting market was valued at $2.2 billion in 2024, and is expected to reach $6.82 billion by 2034. The market is expected to grow at a compound annual growth rate (CAGR) of 18.51% from 2022 to 2030, reaching $8.3 billion by 2030.
What RPSA Offers
-
High Resolution
-
Variable Data Printing
-
Anti Counterfeiting
-
Tamper-Evident Labels
-
Robust Construction
-
Consistent Performance
-
Wide range of inks
-
Specialty inks